Mikael Dolsten - 17 Dec 2021 Form 4 Insider Report for PFIZER INC (PFE)

Role: President R&D
Signature: Susan E. Grant, by power of atty., for Mikael Dolsten
Issuer symbol: PFE
Transactions as of: 17 Dec 2021
Transactions value $: $647,686
Form type: 4
Filing time: 21 Dec 2021, 17:31:55 UTC
Previous filing: 15 Nov 2021
Next filing: 25 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PFE	Common Stock	Options Exercise	$2,147,711	+71,187	+25%	$30.17	351,637	17 Dec 2021	Direct	F1
holding	PFE	Common Stock						1,802	17 Dec 2021	By Rule 16b-3 Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PFE	Phantom Stock Units	Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities	-$1,500,026	-25,219	-35%	$59.48	45,983	17 Dec 2021	Common Stock	25,219		Direct	F2, F3, F4
transaction	PFE	Stock Appreciation Rights	Options Exercise	$0	-152,085	-100%	$0^*	0	17 Dec 2021	Common Stock	152,085	$30.17	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of stock units received upon the exercise and conversion of previously granted stock appreciation rights (SARs), calculated by taking the change in Pfizer common stock price (20 trading day average ending on the exercise date (Election Price of $53.791)) less the grant price of the SAR plus accumulated dividends from the grant date, times the number of SARs exercised. This value is divided by the Election Price to determine the number of stock units. The stock units and accumulated dividend units will be settled in Pfizer common stock on the SAR original settlement date, the fifth anniversary of grant.
F2	Each unit represents one phantom share of common stock.
F3	The reporting person diversified shares held in the Pfizer Inc. Deferred Compensation Plan (Plan) pursuant to the Plan's diversification provision into an alternate investment option(s) under the Plan.
F4	The units, held under the Deferred Compensation Plan, are paid in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.